Thank you for standing by. This is the conference operator. Welcome to the XS Financial Inc. Third Quarter 2023 Results Conference Call. [Operator Instructions] And the conference is being recorded. [Operator Instructions]
I would now like to turn the conference over to David Kivitz, CEO. Please go ahead, David.
Good afternoon, everyone, and welcome to XS Financial's Third Quarter 2023 Earnings Call. We are excited to share our financial results for the quarter with you today. I encourage everyone to visit our website at xsfinancial.com/investors for the most up-to-date corporate presentations, news and upcoming events. Our financial statements and MD&A for the third quarter ended September 30, 2023, have been filed on sedar.com. We will be taking questions at the end of the call. So please feel free to send in any questions you might have.
The third quarter of 2023 was highlighted by strong revenue, record net distributable earnings and positive operational performance. We are focused on profitability and risk mitigation. And given the lack of available financing in cannabis and our unique vendor partnerships, we are working to maximize return on new leases.
XS has received industry-wide recognition as a better alternative for non-dilutive CapEx and equipment financing and continues its focus on customer expansion and service. While we continue seeing a slowdown in the cannabis market relative to prior years, our pipeline remains active with both existing and prospective customers.
Our non-dilutive financing is a welcome solution as equity valuations for plant-touching cannabis companies continue to see challenges. As states continue to expand from additional markets to adult use and new states legalized, different capital solutions are being explored from our current partners and new prospects.
We believe our current competitive non-dilutive financing to purchase CapEx and equipment nationwide continues to see a significant runway as one of the only institutional platforms for companies within the cannabis industry and results to date have solidified that assumption.
We have over $21 million of availability to fund our near- to medium-term pipeline under our credit facility with 2 bank syndication partners, which has a borrowing rate of prime plus 100 basis points and was upsized to $54 million this quarter. We are proud to be one of the few companies to solidify a credit facility from a commercial bank syndicate in the cannabis space, which is a testament to our underwriting capabilities, portfolio strength and employee talent.
Our credit facility, along with our convertible notes and debentures mature in 2024. We are working with our lending partners as well as speaking with prospective new funding alternatives to determine the best future financing structure for the business.
Our third quarter of 2023 continued our historically strong trends, which delivered increased revenue growth and monthly recurring customer payments. At the end of Q3, we had 224 active lease schedules compared to 209 at the end of Q2 2023. Currently active in 15 states. We have achieved broad diversification across several existing markets and we are ensuring that our infrastructure will support our partners wherever the market is headed as cultivators, processors and manufacturers seek out alternative financing solutions, our trustworthy, transparent and reliable funding for CapEx needs is continually relevant and sought out.
With that said, I would now like to turn the call over to Justin Vuong, our CFO, who will provide more detail on our financial results for the third quarter ended September 30, 2023.
Thank you, David. I will now walk you through the key points of our financial results for the third quarter ended September 30, 2023. In Q3, XS Financial delivered another strong quarter. Our revenue was $2.9 million, representing a year-over-year increase of 41% compared to Q3 2022. Our gross receivables increased to $113 million compared to $99 million a year ago, and we have 224 active leases across 16 customers as of the end of the quarter.
Our operating expenses were $1.1 million compared to $1.9 million in the same quarter last year. The decrease was primarily a result of noncash incentive compensation expense that was paid in the same period last year.
Our net loss for Q3 was $3 million or $0.03 per share. Our net distributable earnings, which is a non-IFRS metric we use as a proxy for cash earnings was positive $209,000 in the quarter compared to $189,000 a year ago. You can find a breakdown of that calculation in our earnings press release. As of the end of the quarter, we had $87,000 in cash and $20 million in availability on our line of credit. Combined with our $3.3 million in monthly receivables, the company has adequate liquidity to fund future leases.
With that, I will turn the call back over to David for closing remarks.
Thank you, Justin, for that insightful overview of our financial results. As we reflect on the past year, we are proud of our achievements and the progress we have made in establishing XS Financial as a leader in the CapEx finance industry. As we look ahead, we are excited about the opportunities for our business. We remain focused on executing our growth strategy while maintaining our strong underwriting policies, risk management framework and commitment to sustainability.
I want to thank our employees, partners and shareholders for their continued support and dedication. We look forward to delivering continued growth and value to all of our stakeholders in the years to come. Thank you all for joining us today. We will now send it back to the operator for questions.
[Operator Instructions] As there are no questions from the phone line, this concludes the question-and-answer session and today's conference call. You may disconnect your lines.
Thank you for participating, and have a pleasant day.
